(BMRN) - Analyzing Biomarin Pharmaceutical's Short Interest
(BMRN) - Analyzing Biomarin Pharmaceutical's Short Interest
Biomarin Pharmaceutical's (NYSE:BMRN) short percent of float has fallen 8.08% since its last report. The company recently reported that it has 6.88 million shares sold short, which is 3.64% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.45 days to cover their short positions on average.
拜玛林制药(NYSE:BMRN)的空头占流通股比例自上次报告以来下降了8.08%。该公司最近报告称,有688万股空头卖出,占可进行交易的所有普通股的3.64%。根据其交易量,交易者平均需要5.45天来平仓他们的空头仓位。
Why Short Interest Matters
为什么空头持仓很重要?
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
空头持仓是指已经卖出但尚未偿还或关闭的股票数量。空头卖空是指交易者卖出一家公司的股票,但他们并未拥有这些股票,希望股票价格会下跌。如果股票价格下跌,交易者通过空头卖空可以赚钱,如果股票价格上涨,则会亏本。
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
跟踪空头持仓很重要,因为它可以作为市场对特定股票情绪的指标。空头持仓增加可能表明投资者变得更看淡,而空头持仓减少可能表明他们变得更看好。
List of the most shorted stocks
最受做空集合股的名单
Biomarin Pharmaceutical Short Interest Graph (3 Months)
拜玛林制药空头持仓图表(3个月)
![1724256021_0.png](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240822/42678221-0-bb1d372060a15c4728f4409968610d52.png/big)
As you can see from the chart above the percentage of shares that are sold short for Biomarin Pharmaceutical has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
从上图可以看出,拜玛林制药的做空股份占比自上次报告以来有所下降。这并不意味着股票近期会上涨,但交易者应该意识到做空股份减少了。
Comparing Biomarin Pharmaceutical's Short Interest Against Its Peers
将拜玛林制药的空头持仓与其同业公司进行比较
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
对分析师和投资人而言,同业对比是衡量公司业绩的流行技术。某公司的同业是与其具有相似特征的另一家公司,如行业、规模、年龄和财务结构等。您可以通过阅读公司的10-k、代理申报文件或进行自己的相似性分析来确定公司的同业群体。
According to Benzinga Pro, Biomarin Pharmaceutical's peer group average for short interest as a percentage of float is 6.33%, which means the company has less short interest than most of its peers.
根据Benzinga Pro的数据,拜玛林制药的同行平均空头持仓占流通股比例为6.33%,这意味着该公司的空头持仓比大多数同行公司要少。
Did you know that increasing short interest can actually be bullish for a stock? This post by Benzinga Money explains how you can profit from it.
您是否知道,空头持仓增加实际上对股票有利?这篇文章由Benzinga Money撰写,解释了如何从中获利。
This article was generated by Benzinga's automated content engine and was reviewed by an editor.
本文由Benzinga的自动化内容引擎生成,并由编辑进行了审核。